242 related articles for article (PubMed ID: 30469158)
1. Advanced Adrenocortical Carcinoma - What to do when First-Line Therapy Fails?
Megerle F; Kroiss M; Hahner S; Fassnacht M
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):109-116. PubMed ID: 30469158
[TBL] [Abstract][Full Text] [Related]
2. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of adrenocortical carcinoma.
Fassnacht M; Allolio B
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):273-89. PubMed ID: 19500769
[TBL] [Abstract][Full Text] [Related]
4. Update in adrenocortical carcinoma.
Fassnacht M; Kroiss M; Allolio B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
[TBL] [Abstract][Full Text] [Related]
5. Contemporary management of adrenocortical carcinoma.
Zini L; Porpiglia F; Fassnacht M
Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: A single center experience.
Bronswijk MJH; Laenen A; Bechter OE
Neoplasma; 2020 Jan; 67(1):209-213. PubMed ID: 31777255
[TBL] [Abstract][Full Text] [Related]
7. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.
Payabyab EC; Balasubramaniam S; Edgerly M; Velarde M; Merino MJ; Venkatesan AM; Leuva H; Litman T; Bates SE; Fojo T
Clin Cancer Res; 2016 Oct; 22(20):4989-5000. PubMed ID: 27742785
[TBL] [Abstract][Full Text] [Related]
9. Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells.
Gagliano T; Gentilin E; Benfini K; Di Pasquale C; Tassinari M; Falletta S; Feo C; Tagliati F; Uberti ED; Zatelli MC
Endocrine; 2014 Dec; 47(3):943-51. PubMed ID: 25096913
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical carcinoma.
van Ditzhuijsen CI; van de Weijer R; Haak HR
Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M; Terzolo M; Allolio B; Baudin E; Haak H; Berruti A; Welin S; Schade-Brittinger C; Lacroix A; Jarzab B; Sorbye H; Torpy DJ; Stepan V; Schteingart DE; Arlt W; Kroiss M; Leboulleux S; Sperone P; Sundin A; Hermsen I; Hahner S; Willenberg HS; Tabarin A; Quinkler M; de la Fouchardière C; Schlumberger M; Mantero F; Weismann D; Beuschlein F; Gelderblom H; Wilmink H; Sender M; Edgerly M; Kenn W; Fojo T; Müller HH; Skogseid B;
N Engl J Med; 2012 Jun; 366(23):2189-97. PubMed ID: 22551107
[TBL] [Abstract][Full Text] [Related]
12. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.
Wortmann S; Quinkler M; Ritter C; Kroiss M; Johanssen S; Hahner S; Allolio B; Fassnacht M
Eur J Endocrinol; 2010 Feb; 162(2):349-56. PubMed ID: 19903796
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
[TBL] [Abstract][Full Text] [Related]
15. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical carcinoma: current treatment options.
De Filpo G; Mannelli M; Canu L
Curr Opin Oncol; 2021 Jan; 33(1):16-22. PubMed ID: 33186181
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, treatment and outcome of adrenocortical cancer.
Mihai R
Br J Surg; 2015 Mar; 102(4):291-306. PubMed ID: 25689291
[TBL] [Abstract][Full Text] [Related]
19. Multi-Target Approach to Metastatic Adrenal Cell Carcinoma.
Wahab NA; Zainudin S; AbAziz A; Mustafa N; Sukor N; Kamaruddin NA
Arch Iran Med; 2016 Sep; 19(9):671-3. PubMed ID: 27631184
[TBL] [Abstract][Full Text] [Related]
20. Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma.
Jung S; Nagy Z; Fassnacht M; Zambetti G; Weiss M; Reincke M; Igaz P; Beuschlein F; Hantel C
Endocr Relat Cancer; 2016 Oct; 23(10):825-37. PubMed ID: 27550961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
